NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

壓力管理產業:全球趨勢

Stress Management Industry: Global Trends

出版商 BCC Research 商品編碼 926328
出版日期 內容資訊 英文 134 Pages
訂單完成後即時交付
價格
壓力管理產業:全球趨勢 Stress Management Industry: Global Trends
出版日期: 2020年02月20日內容資訊: 英文 134 Pages
簡介

全球壓力管理市場,預計將從2019年到2024年成長3.7%的CAGR,市場規模預測會從2019年的172億美元擴大至2024年的206億美元。醫藥品部門在同樣預測期間中,預期會成長3.1%的CAGR,市場規模預測會從2019年的158億美元擴大至2024年的184億美元。裝置部門在同樣預測期間中,預期會成長9.3%的CAGR,市場規模預測會從2019年的14億美元擴大至2024年的22億美元。

本報告調查了全球壓力管理市場,並分析了全球市場動向分析及CAGR預測、以控制個人壓力等級為目的的多元心理療法與技術、工作相關壓力、憂鬱症或恐慌症的相關資料、罹病率、發生率、法規協定的角色、現在的與開發中的技術、形成壓力管理市場的總體經濟因素,以及主要企業等。

第1章 簡介

  • 調查目標、目的
  • 調查理由
  • 調查範圍
  • 資訊來源
  • 調查方法
  • 地區細項
  • 分析家經歷
  • BCC的客製研究
  • BCC Research的相關報告

第2章 摘要和重點提要

第3章 糖尿病的簡介與對全球健康的威脅

  • 市場動態
  • 抗憂鬱藥的需求低迷
  • 歐洲主宰全球壓力管理市場
  • 政府推動提升對心理健康重視的活動
  • 以經顱磁刺激治療憂鬱症受到新的關注
  • 介紹用於壓力管理的新應用程式
  • ASMR等標示外使用減輕壓力劑的潛在成長
  • 市場力學
  • 促進市場成長的要素
  • 市場成長阻礙要素

第4章 市場細項:治療類型別

  • 藥劑
  • 抗憂鬱藥
  • 非典型抗精神病藥物
  • 乙型交感神經接受體阻斷劑
  • 其他(苯二氮□類)
  • 治療與裝置
  • 腦深層刺激
  • 經顱磁刺激
  • 迷走神經刺激
  • 穿戴式裝置與應用程式
  • ASMR(自發性知覺高潮反應)

第5章 市場分析:終端使用者別

  • 醫院
  • 離院外科診所 (ASC)
  • 其他

第6章 市場分析:年齡層別

  • 小孩
  • 大人
  • 高齡者

第7章 市場分析:地區別

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 其他
  • 亞洲及太平洋
  • 中國
  • 印度
  • 日本
  • 其他亞太地區
  • 其他地區 (ROW)
  • 巴西
  • 墨西哥
  • 南非

第8章 專利審查/新的開發

第9章 市場機會分析

  • 採用減緩壓力的穿戴式及智慧型裝置的情形增加
  • 用於神經治療的重要FDA認可
  • 最近的FDA認可
  • 主要供應商與廠商
  • Eli Lilly and Co.
  • 大塚控股集團
  • H. Lundbeck A/S
  • Johnson&Johnson Services Inc.
  • AstraZeneca PLC
  • 策略
  • 產品發售與認可
  • 合作與夥伴關係
  • 地理性擴大

第10章 企業檔案

  • ABBOTT LABORATORIES INC.
  • ALKERMES PLC
  • ALLERGAN PLC
  • APPLE INC.
  • ASTRAZENECA PLC
  • AZUMIO INC.
  • BAUSCH HEALTH COMPANIES INC.
  • BEIJING PINS MEDICAL CO., LTD.
  • BIOCONTROL MEDICAL LTD.
  • BRAINSWAY LTD.
  • BRISTOL-MYERS SQUIBB CO.
  • CAEDEN INC.
  • DARTA SYSTEMS
  • DEVON MEDICAL PRODUCTS INC.
  • ELECTROMEDICAL PRODUCTS INTERNATIONAL INC.
  • ELI LILLY AND CO.
  • F. HOFFMANN-LA ROCHE AG
  • FACEMETRICS LTD.
  • FISHER WALLACE LABORATORIES INC.
  • FITBIT INC.
  • GARMIN LTD.
  • GLAXOSMITHKLINE PLC
  • H. LUNDBECK A/S
  • HEADSPACE INC.
  • IBREVE LTD.
  • INTERAXON INC.
  • JOHNSON & JOHNSON SERVICES INC.
  • LIEF THERAPEUTICS
  • LIVANOVA PLC
  • LUPIN LTD.
  • MAG & MORE GMBH
  • MAGVENTURE INC.
  • MERCK & CO. INC.
  • MOOD TRACKER WEB MEDIA LLC
  • MYLAN N.V.
  • NEURONETICS INC.
  • NEUROSIGMA INC.
  • NEUVANA LLC
  • 大塚製藥
  • PFIZER INC.
  • SAMSUNG ELECTRONICS CO., LTD.
  • SANVELLO HEALTH INC.
  • SPIRE INC.
  • 武田藥品
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.
  • THYNC GLOBAL INC.
  • TINGLES INC.
  • WALDEN MEDICAL NEURO DIGITAL THERAPIES LLC
目錄
Product Code: HLC256A

Report Highlights:

The global stress management treatments market should reach $20.6 billion by 2024 from $17.2 billion in 2019 at a compound annual growth rate (CAGR) of 3.7% for the forecast period of 2019 to 2024.

The drugs and medications segment of the global stress management treatments market is expected to grow from $15.8 billion in 2019 to $18.4 billion in 2024 at a CAGR of 3.1% for the forecast period of 2019 to 2024.

The therapy and devices segment of the global stress management treatments market is expected to grow from $1.4 billion in 2019 to $2.2 billion in 2024 at a CAGR of 9.3% for the forecast period of 2019 to 2024.

Report Scope:

The report offers an exhaustive description and evaluation of the global stress management market. It provides in-depth qualitative and quantitative insights into the report, which aligns with the goals and objectives of our intended customers. The projections are verified through intensive primary and secondary research. The report will enable clients to obtain investment in the stress management industry on the basis of the current business scenario, trends and futuristic development in the segments. Keeping in mind the client's needs, the report provides expert insights into the global stress management industry, its services and market trends. The market is forecasted through a bottom-up approach, which includes evaluation of the market through revenues generated by the key vendors of the market. It consists of market statistics that are unveiled by affirmed private publishers and various public organizations. The data encompasses the vogue and the newest industry players along with their pre-eminent company profiles. The information is thoroughly examined through extensive primary and secondary research carried by the research analysts.

The global stress management market has been segmented on the basis of mode of treatment, end user and age group. Geographically, the market has been divided into North America, Europe, Asia-Pacific (APAC) and the Rest of the World (RoW). A country-specific breakdown of the market is also included in the report. The study covers the global stress management market irrespective of the included countries. Countries were included mainly on the basis of total revenue generated. Major countries included in the report are the U.S., Canada, Germany, the U.K., Spain, Italy, France, China, Japan, South Korea and India. Sales data for the global and regional markets were corroborated for the present and forecasted values based on statistical analysis.

Estimated values used are based on market players' total revenues and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation. Annual reports and forward-looking statement of stress management market players, annual sales of market players and average cost of software and services are considered for market estimations. A large number of stress management market players and potential startups are profiled in the report for a better understanding of the market.

The report on the stress management market provides a market overview, assesses modes of treatment, provides an end-user analysis, and analyzes the stress management market by mode of treatment, age group and end user. The major companies that were profiled in the report includes a detailed introduction, product portfolios and recent developments. The report also includes regulatory aspects, current and developing technologies, market projections, and market shares.

Report Includes:

  • 52 tables
  • Detailed study and industry analysis of the global stress management market
  • Analyses of the global market trends with data from 2018 to 2019, and projections of compound annual growth rates (CAGRs) through 2024
  • A broad range of psychotherapies and techniques that are aimed at controlling the level of stress in individuals, primarily chronic stress along with several drugs and devices, available in the market for the treatment of stress
  • Data corresponding to number of cases of work-related stress, depression or anxiety; as well as the prevalence and incidence rates
  • Elaboration on the role of regulatory protocols, current and developing technologies, and other macroeconomic factors shaping the stress management marketplace
  • Profile description of market leading companies, their product portfolios and recent developments, including Abbott Laboratories Inc., Eli Lilly and Co., GlaxoSmithKline PLC, Lupin Ltd., Johnson & Johnson Services Inc., Merck & Co. Inc., Pfizer Inc. and Takeda Pharmaceutical Co., Ltd.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Market and Technology Background

  • Market Trends
    • Antidepressant Demand Slows
    • Europe Dominates the Global Stress Management Market
    • Government Awareness Campaigns for Mental Health
    • Emerging Focus on Transcranial Magnetic Stimulation for Depression
    • Introduction of New Apps for Stress Management
    • Potential Growth of Off-Label Stress Reducers Such as ASMR
  • Market Dynamics
    • Factors Driving the Growth of the Market
    • Restraints

Chapter 4: Market Breakdown by Treatment Type

  • Drugs and Medications
    • Antidepressant Drugs
    • Atypical Antipsychotics
    • Beta-Blockers
    • Others (Benzodiazepines)
  • Therapies and Devices
    • Deep Brain Stimulation
    • Transcranial Magnetic Stimulation
    • Vagus Nerve Stimulation
    • Wearable Devices and Apps
    • ASMR (Autonomous Sensory Meridian Response)

Chapter 5: Market Breakdown by End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Chapter 6: Market Breakdown by Age Group

  • Children
  • Adults
  • Elderly

Chapter 7: Market Breakdown by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • Rest of the World
    • Brazil
    • Mexico
    • South Africa

Chapter 8: Patent Review/New Developments

Chapter 9: Analysis of Market Opportunities

  • Increasing Adoption of Wearables and Smart Devices for Stress Relief
  • Significant FDA Approvals for Neurological Therapies
    • Recent FDA Approvals
  • Key Suppliers and Manufacturers
    • Eli Lilly and Co.
    • Otsuka Holding Co., Ltd.
    • H. Lundbeck A/S
    • Johnson & Johnson Services Inc.
    • AstraZeneca PLC
  • Strategies
    • Product Launches and Approvals
    • Collaborations and Partnerships
    • Geographical Expansion

Chapter 10: Company Profiles

  • ABBOTT LABORATORIES INC.
  • ALKERMES PLC
  • ALLERGAN PLC
  • APPLE INC.
  • ASTRAZENECA PLC
  • AZUMIO INC.
  • BAUSCH HEALTH COMPANIES INC.
  • BEIJING PINS MEDICAL CO., LTD.
  • BIOCONTROL MEDICAL LTD.
  • BRAINSWAY LTD.
  • BRISTOL-MYERS SQUIBB CO.
  • CAEDEN INC.
  • DARTA SYSTEMS
  • DEVON MEDICAL PRODUCTS INC.
  • ELECTROMEDICAL PRODUCTS INTERNATIONAL INC.
  • ELI LILLY AND CO.
  • F. HOFFMANN-LA ROCHE AG
  • FACEMETRICS LTD.
  • FISHER WALLACE LABORATORIES INC.
  • FITBIT INC.
  • GARMIN LTD.
  • GLAXOSMITHKLINE PLC
  • H. LUNDBECK A/S
  • HEADSPACE INC.
  • IBREVE LTD.
  • INTERAXON INC.
  • JOHNSON & JOHNSON SERVICES INC.
  • LIEF THERAPEUTICS
  • LIVANOVA PLC
  • LUPIN LTD.
  • MAG & MORE GMBH
  • MAGVENTURE INC.
  • MERCK & CO. INC.
  • MOOD TRACKER WEB MEDIA LLC
  • MYLAN N.V.
  • NEURONETICS INC.
  • NEUROSIGMA INC.
  • NEUVANA LLC
  • OTSUKA PHARMACEUTICAL CO., LTD.
  • PFIZER INC.
  • SAMSUNG ELECTRONICS CO., LTD.
  • SANVELLO HEALTH INC.
  • SPIRE INC.
  • TAKEDA PHARMACEUTICAL CO., LTD.
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.
  • THYNC GLOBAL INC.
  • TINGLES INC.
  • WALDEN MEDICAL NEURO DIGITAL THERAPIES LLC

List of Tables

  • Summary Table: Global Market for Stress Management Treatments, by Type, Through 2024
    • Table 1: Source of Stress Related to Specific Job Type
    • Table 2: Most Common SSRIs and Their Side Effects
    • Table 3: Global Market for Stress Management Treatments, by Type, Through 2024
    • Table 4: Global Market for Stress Management Treatments, by Drug Type, Through 2024
    • Table 5: Major Drug Classes Used in the Treatment of Stress-Associated Disorders
    • Table 6: Global Market for Drugs and Medications Used for Stress Management, by Region, Through 2024
    • Table 7: FDA Approved Antidepressants
    • Table 8: Details of Atypical Antipsychotic Drugs
    • Table 9: Global Market for Therapies and Devices Used in Stress Management, by Type, Through 2024
    • Table 10: Global Market for Therapies and Devices Used in Stress Management, by Region, Through 2024
    • Table 11: Wearable Devices and Apps Used for Stress Management
    • Table 12: Global Market for Stress Management Treatments, by End User, Through 2024
    • Table 13: Common Stress Management Services Offered in Hospitals
    • Table 14: Global Market for Stress Management Treatments in Hospitals and Clinics, by Region, Through 2024
    • Table 15: Global Market for Stress Management Treatments in Ambulatory Surgical Centers, by Region, Through 2024
    • Table 16: Global Market for Stress Management Treatments in Other End Uses, by Region, Through 2024
    • Table 17: Global Market for Stress Management Treatments, by Age Group, Through 2024
    • Table 18: Global Market for Stress Management Treatments for Children, by Region, Through 2024
    • Table 19: Major Causes of Stress Among Adults in the U.S.
    • Table 20: Global Market for Stress Management Treatments for Adults, by Region, Through 2024
    • Table 21: Global Market for Stress Management Treatments for the Elderly, by Region, Through 2024
    • Table 22: Global Market for Stress Management Treatments, by Region, Through 2024
    • Table 23: North American Market for Stress Management Treatments, by Type, Through 2024
    • Table 24: North American Market for Stress Management Treatments, by End User, Through 2024
    • Table 25: North American Market for Stress Management Treatments, by Age Group, Through 2024
    • Table 26: North American Market for Stress Management Treatments, by Country, Through 2024
    • Table 27: Canada's Mental Health Resources, 2017
    • Table 28: European Market for Stress Management Treatments, by Type, Through 2024
    • Table 29: European Market for Stress Management Treatments, by End User, Through 2024
    • Table 30: European Market for Stress Management Treatments, by Age Group, Through 2024
    • Table 31: European Market for Stress Management Treatments, by Country, Through 2024
    • Table 32: Germany's Mental Health Resources, 2017
    • Table 33: France's Mental Health Resources, 2017
    • Table 34: Italy's Mental Health Resources, 2017
    • Table 35: Spain's Mental Health Resources, 2017
    • Table 36: Asia-Pacific Market for Stress Management Treatments, by Type, Through 2024
    • Table 37: Asia-Pacific Market for Stress Management Treatments, by End User, Through 2024
    • Table 38: Asia-Pacific Market for Stress Management Treatments, by Age Group, Through 2024
    • Table 39: Asia-Pacific Market for Stress Management Treatments, by Country, Through 2024
    • Table 40: China's Mental Health Resources, 2017
    • Table 41: India's Mental Health Resources, 2017
    • Table 42: Rest of the World Market for Stress Management Treatments, by Type, Through 2024
    • Table 43: Rest of the World Market for Stress Management Treatments, by End User, Through 2024
    • Table 44: Rest of the World Market for Stress Management Treatments, by Age Group, Through 2024
    • Table 45: Patents on Stress Management Treatments, by Category in Different Countries, January 2016-August 2019
    • Table 46: Distribution of Major Patents on Stress Management Treatments, by Assignee, January 2016-December 2019
    • Table 47: Total Patents Analyzed for Stress Management Treatments, January 2016-December 2019
    • Table 48: Eli Lilly and Co.: Product Sales, by Country/Region, 2018
    • Table 49: Otsuka Pharmaceutical's Clinical Trials on Stress Management Treatments
    • Table 50: H. Lundbeck: Product Sales, 2017 and 2018
    • Table 51: Johnson & Johnson: Revenue Generated from Drugs Used in the Treatment of Depression, 2017 and 2018

List of Figures

  • Summary Figure: Global Market for Stress Management Treatments, by Type, 2018-2024
    • Figure 1: Breakdown of Mental Health-Related Insurance Claims, 2012-2017
    • Figure 2: Share of Claims Tied to Generalized Anxiety Disorder Among Young People, 2014-2017
    • Figure 3: Global Distribution of Diseases Causing Loss of Work Output, by Disease Type, 2018
    • Figure 4: Global Incidence of Major Depressive Disorder, by Region, 2015-2017
    • Figure 5: Behavioral Changes in Children: Depression and Anxiety, by Age Group, 2015
    • Figure 6: Incidence of Anxiety Disorders in North America, 2013-2017
    • Figure 7: Prevalence of Depressive Disorder in the U.S., 2013-2017
    • Figure 8: Number of Clinical Studies Based on Trauma, by Type, 1988-2018
    • Figure 9: Prevalence of Depressive Disorder in Canada, 2013-2017
    • Figure 10: Regional European Shares of Populations with Behavioral Health Disorders, by Type of Disorder, 2017
    • Figure 11: Percentage of U.K.'s Population with Behavioral Health Disorders, by Type of Disorder, 2017
    • Figure 12: Percentage of Germany's Population with Behavioral Health Disorders, by Type of Disorder, 2017
    • Figure 13: Percentage of France's Population with Behavioral Health Disorders, by Type of Disorder, 2017
    • Figure 14: Percentage of Italy's Population with Behavioral Health Disorders, by Type of Disorder, 2017
    • Figure 15: Percentage of Spain's Population with Behavioral Health Disorders, by Type of Disorder, 2017
    • Figure 16: Percentage of Asia-Pacific's Population with Depression, by Country, 2017
    • Figure 17: Percentage of China's Population with Behavioral Health Disorders, by Type of Disorder, 2015-2017
    • Figure 18: Percentage of India's Population with Behavioral Health Disorders, by Type of Disorder, 2015-2017
    • Figure 19: Percentage of Japan's Population with Behavioral Disorders, by Type of Disorder, 2017
    • Figure 20: Percentage of Australia's Population with Behavioral Disorders, by Type of Disorder, 2017
    • Figure 21: Prevalence of Major Stress Disorders in Latin America, by Type of Disorder, 2015-2017
    • Figure 22: Prevalence of Major Stress Disorders in Brazil, by Type of Disorder, 2015-2017
    • Figure 23: Prevalence of Stress Disorders in Mexico, by Type of Disorder, 2015-2017
    • Figure 24: Prevalence of Major Stress Disorders in South Africa, by Type of Disorder, 2015-2017